PlainRecalls
FDA Drug Moderate Class II Terminated

Amantadine HCl Capsules, USP, 100 mg, 50 Capsules (5x10) Unite Dose, Rx Only, Manufactured for: AvKARE Inc. Pulaski, TN 38478 --- NDC 50268-069-15

Reported: April 25, 2018 Initiated: March 30, 2018 #D-0633-2018

Product Description

Amantadine HCl Capsules, USP, 100 mg, 50 Capsules (5x10) Unite Dose, Rx Only, Manufactured for: AvKARE Inc. Pulaski, TN 38478 --- NDC 50268-069-15

Reason for Recall

Failed Dissolution Specifications

Details

Recalling Firm
AVKARE Inc.
Units Affected
2135 cartons
Distribution
Nationwide
Location
Pulaski, TN

Frequently Asked Questions

What product was recalled?
Amantadine HCl Capsules, USP, 100 mg, 50 Capsules (5x10) Unite Dose, Rx Only, Manufactured for: AvKARE Inc. Pulaski, TN 38478 --- NDC 50268-069-15. Recalled by AVKARE Inc.. Units affected: 2135 cartons.
Why was this product recalled?
Failed Dissolution Specifications
Which agency issued this recall?
This recall was issued by the FDA Drug on April 25, 2018. Severity: Moderate. Recall number: D-0633-2018.